Company Closes $20 Million Series A Led by Frist Cressey Ventures and backed by Morgan Health and Andreessen Horowitz ...

Cloud-based platform combines AI and machine learning to perform multivariate analysis, enabling real-time optimization of cell therapy performance and patient outcomes ...

Scientists have used a new type of gene therapy to cure leukaemia patients. The treatment, which uses edited immune cells ...

Kids and teenagers with spinal muscular atrophy had more mobility after receiving a single-dose gene replacement therapy, ...

Doctors have discovered that a new groundbreaking therapy has reversed incurable blood cancers in some patients.A therapy, ...

P atients with previously incurable cancer are seeing incredible results thanks to a pioneering new treatment that has just ...

Miltenyi Biotec has been honoured with the Special Recognition Award for Pioneering Work in Cell and Gene Therapy at the ...

A new wave of gene therapy treatments offer a new lease on life for people with inherited diseases such as haemophilia. But ...

The FDA is raising the bar for approval of CAR T-cell therapies in oncology. | The FDA is raising the bar for approval of CAR ...

The status could support staged transitions to new manufacturing processes, potentially mitigating some risks of high-stakes ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) ...

Jesse Tettero presented data supporting the use of a measurable residual disease (MRD) surrogate endpoint in acute myeloid leukemia (AML) research. Through the Harmony Alliance study of 1,858 pooled ...